These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 4148269)

  • 1. II. Medical treatment of inflammatory bowel disease.
    Gray GM
    Calif Med; 1973 Nov; 119(5):21-4. PubMed ID: 4148269
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunomodulation treatment of inflammatory bowel disease].
    Stave R
    Tidsskr Nor Laegeforen; 1984 Jan; 104(3):153-4. PubMed ID: 6142543
    [No Abstract]   [Full Text] [Related]  

  • 3. Inflammatory bowel disease. Part II.
    Hansen R
    Proc Annu Meet Med Sect Am Counc Life Insur; 1978; ():41-9. PubMed ID: 39296
    [No Abstract]   [Full Text] [Related]  

  • 4. The drug therapy of ulcerative colitis and of Crohn's disease.
    Tumen HJ
    Semin Drug Treat; 1974; 3(4):339-49. PubMed ID: 4150770
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacotherapy of inflammatory bowel disease.
    Gardner RC
    J Maine Med Assoc; 1976 Jul; 67(7):206-14. PubMed ID: 9461
    [No Abstract]   [Full Text] [Related]  

  • 6. Sulphasalazine in inflammatory bowel disease: recent advances.
    Cooper BT
    N Z Med J; 1986 Oct; 99(811):757-9. PubMed ID: 2877428
    [No Abstract]   [Full Text] [Related]  

  • 7. [An approach to the medical management of inflammatory bowel disease (author's transl)].
    Bartnik W; Shorter RG
    Przegl Lek; 1981; 38(6):499-505. PubMed ID: 6115454
    [No Abstract]   [Full Text] [Related]  

  • 8. [Recurrence-preventive (remission preserving) therapy of chronic inflammatory bowel diseases].
    Kruis W; Pohl C
    Dtsch Med Wochenschr; 1998 Jan; 123(4):85-7. PubMed ID: 9487288
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of chronic inflammatory intestinal diseases with 5-aminosalicylic acid].
    Malchow H
    Internist (Berl); 1987 Jan; 28(1):14-20. PubMed ID: 2883152
    [No Abstract]   [Full Text] [Related]  

  • 10. [Salazosulfapyridine: old and new therapy concepts in inflammatory bowel diseases].
    Allgayer H; Kruis W
    Dtsch Med Wochenschr; 1985 Nov; 110(47):1827-9. PubMed ID: 2866083
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacotherapy of inflammatory bowel disease.
    Gardner RC
    Am J Hosp Pharm; 1976 Aug; 33(8):831-8. PubMed ID: 782236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Locally acting glucocorticoids in chronic intestinal inflammation].
    Lamers CB; van der Sluys Veer A; Wagtmans MJ; van Hogezand RA
    Ned Tijdschr Geneeskd; 1994 Dec; 138(51):2533-5. PubMed ID: 7830800
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of sulfasalazine in the treatment of inflammatory bowel disease.
    Spector R
    J Iowa Med Soc; 1983 Jun; 73(6):230-4. PubMed ID: 6135735
    [No Abstract]   [Full Text] [Related]  

  • 14. Imparied lymphocyte responsiveness in inflammatory bowel disease.
    Sachar DB; Taub RN; Brown SM; Present DH; Korelitz BI; Janowitz HD
    Gastroenterology; 1973 Feb; 64(2):203-9. PubMed ID: 4405597
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug management of inflammatory bowel disease.
    McCarthy CF
    Ir Med J; 1983 May; 76(5):260-2. PubMed ID: 6135675
    [No Abstract]   [Full Text] [Related]  

  • 16. The immunology of inflammatory bowel disease.
    MacKechnie HL
    Henry Ford Hosp Med J; 1982; 30(1):25-32. PubMed ID: 6123493
    [No Abstract]   [Full Text] [Related]  

  • 17. Sulfasalazine therapy in inflammatory bowel disease.
    Das KM
    Gastroenterol Clin North Am; 1989 Mar; 18(1):1-20. PubMed ID: 2563989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic experience with ulcerative colitis and Crohn disease].
    Nagy G; Prónay G; Ujszászy L
    Orv Hetil; 1985 Jan; 126(1):17-20, 23-4. PubMed ID: 2857480
    [No Abstract]   [Full Text] [Related]  

  • 19. 1986 Stuart distinguished lecture. The "natural history" of inflammatory bowel disease and therapeutic decisions.
    Janowitz HD
    Am J Gastroenterol; 1987 Jun; 82(6):498-503. PubMed ID: 2883884
    [No Abstract]   [Full Text] [Related]  

  • 20. [New developments and trends in the drug therapy of chronic inflammatory bowel diseases].
    Ewe K
    Verh Dtsch Ges Inn Med; 1988; 94():178-84. PubMed ID: 2905098
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.